These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30550505)

  • 41. Procalcitonin to guide antibiotic therapy in the ICU.
    Bréchot N; Hékimian G; Chastre J; Luyt CE
    Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S19-24. PubMed ID: 26607343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
    Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
    Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
    Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
    J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter?
    Kiser TH; Vandivier RW
    Curr Opin Pulm Med; 2015 Mar; 21(2):142-8. PubMed ID: 25575365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Procalcitonin-Guided Antibiotic Prescribing for Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Emergency Department.
    Nguyen LJ; Varker A; Slaughter P; Boyle D; Nekahi N
    Fed Pract; 2021 Jun; 38(6):264-269. PubMed ID: 34733073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
    Steuten L; Mewes J; Lepage-Nefkens I; Vrijhoef H
    OMICS; 2018 Sep; 22(9):616-625. PubMed ID: 30235108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections?
    Pantelidou IM; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S10-2. PubMed ID: 26686272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?
    Pazarli AC; Koseoglu HI; Doruk S; Sahin S; Etikan I; Celikel S; Berktas B
    J Res Med Sci; 2012 Nov; 17(11):1047-51. PubMed ID: 23833579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D-Dimer and Procalcitonin Improve the Sensitivity of BAP-65 Score in Predicting AECOPD Patients Admission to ICU.
    Zhang Q; Liu JX; Bai JS; Wang JM; Fu AS; Liu RX; Zhou XY; Gao S; Chen QC; Zhang JB; Ge YL
    Clin Lab; 2023 Feb; 69(2):. PubMed ID: 36787555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Procalcitonin in special patient populations: Guidance for antimicrobial therapy.
    Smith SE; Muir J; Kalabalik-Hoganson J
    Am J Health Syst Pharm; 2020 May; 77(10):745-758. PubMed ID: 32340027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU.
    Daubin C; Fournel F; Thiollière F; Daviaud F; Ramakers M; Polito A; Flocard B; Valette X; Du Cheyron D; Terzi N; Fartoukh M; Allouche S; Parienti JJ;
    Ann Intensive Care; 2021 Mar; 11(1):39. PubMed ID: 33675432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.